US 10080740
Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors
granted A61KA61K31/4192A61K31/454
Quick answer
US patent 10080740 (Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors) held by Aurigene Discovery Technologies Limited expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aurigene Discovery Technologies Limited
- Grant date
- Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/4192, A61K31/454, A61K31/496, A61K31/5377